SCP2 and delirium: The mediation analysis showed that 3-hydroxyoctanoate levels (GCST90026083) accounted for approximately 19.23% of the impact of SCP2 on delirium risk, with a 95% confidence interval (CI) of 0.49 to 37.97%, and Z = 2.011 (p = 0.044).